Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

PEMEX POWDER FOR SOLUTION FOR INJECTION 500MG/VIAL

Approval Number

SIN15621P

Drug Name

PEMEX POWDER FOR SOLUTION FOR INJECTION 500MG/VIAL

Product Name

PEMEX POWDER FOR SOLUTION FOR INJECTION 500MG/VIAL

Approval Date

February 8, 2019

Registrant

DCH AURIGA SINGAPORE

Licence Holder

APEX PHARMA MARKETING PTE. LTD.

Regulatory Information

Registrant

DCH AURIGA SINGAPORE

Licence Holder

APEX PHARMA MARKETING PTE. LTD.

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Route of Administration

INTRAVENOUS

Medical Information

ATC Code

L01BA04

ATC Item Name

pemetrexed

Manufacturer Information

Pharmaceutical Manufacturer

APEX PHARMA MARKETING PTE. LTD.

Manufacturers

JIANGSU HANSOH PHARMACEUTICAL GROUP CO., LTD.

Active Ingredients

Ingredient Name

PEMETREXED DISODIUM HEMIPENTAHYDRATE 604.1mg eqv PEMETREXED

Strength

500mg

Drug MonographPemetrexed

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy